Nurix Therapeutics NRIX
NASDAQ NRIX
$26.02 -0.08 (-0.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2026)

Updated

Nurix Therapeutics (NRIX) recorded Receivables - Net of $19 million in fiscal Q2 2025 (quarter ended May 31, 2025).

Analysis

Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2026) Analysis & Trends

At the end of FY2021 (ended Nov 30, 2021), Nurix Therapeutics reported Receivables - Net of $6 million.

  • The fiscal Q2 2025 figure is the lowest quarterly Receivables - Net since fiscal Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Nurix Therapeutics 2.90 Bn 275.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 20.00 Mn
May 31, 2025 19.00 Mn
Aug 31, 2023 2.00 Mn
Feb 28, 2022 6.00 Mn
Nov 30, 2021 6.00 Mn
May 31, 2021 2.54 Mn
API Access

Nurix Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=NRIX&period=max&api_key=YOUR_API_KEY